TECHNOLOGY

Michael Murphy

Editor,

New World Investor

  • Over 4 Decades of Experience in Tech and Biotech
  • Often Rated #1 by Hulbert, including 5 Years 2008-12
  • Analyst, Advisor, Fund Manager, & Venture Capital

About Michael

Michael Murphy, CFA, has been writing technology investment newsletters for 38 years. He has been a security analyst on the buy-side and sell-side, director of research, mutual fund manager, hedge fund manager, venture capitalist, and CEO of a software company. For the very difficult market in the five years 2008-2012, Mr. Murphy's New World Investor newsletter was rated #1 by The Hulbert Financial Digest.

Michael's Articles

I expect the biggest stock winners in coming years to be in select sectors, such as biotechnology, suggests Michael Murphy, growth stock expert and editor of New World Investor — and a participant in MoneyShow's Accredited Virtual Expo on March 2-4. Register for free here.
QuickLogic (QUIK) — which makes semiconductor devices — is recommended as a play on the mega-shift towards content-on-demand, explains Michael Murphy, editor of New World Investor.
Invitae (NVTA) recently hit a new all-time high; I believe that this company is on track to be the "Amazon of genetic testing" — the clear winner in a winner-take-most industry, suggests biotech expert Michael Murphy, editor of New World Investor.
Despite maintaining bullish long-term positions in various resource, technology, and biotech stocks, Michael Murphy also sees some signs for caution; the editor of New World Investors is also a participant in the upcoming MoneyShow virtual event, August 3-5. Register for free here.

Michael's Videos

Successful venture capital investments offer very high returns, but traditional VC funds often require multi-million-dollar minimum investments. Investing in private companies by yourself on SeedInvest or Wefunder takes a huge amount of time and skill. Rolling venture funds, a new structure, offer professional management for a commitment as small as $5,000 a quarter for two years. Learn how these funds work, what you can expect, and how to get started.

Successful venture capital investments offer very high returns, but traditional VC funds often require multi-million-dollar minimum investments. Investing in private companies by yourself on SeedInvest or Wefunder takes a huge amount of time and skill. Rolling venture funds, a new structure, offer professional management for a commitment as small as $5,000 a quarter for two years. Learn how these funds work, what you can expect, and how to get started.

Small-cap biotech is not affected by the economy and ignored by the institutions and computerized algo traders. You must Be early, be right, and hold on to turn every $1 into $20 over the next few years. Join this session to learn Michael Murphys three early biotech stock picks. Its his job to be right about the science and getting FDA approval. Its your job to hold on until its time to cash in.
Chasing hot stocks, buying tips from TV gurus talking their book, and day trading against the computers often end in tears. Individuals don't have to report quarterly performance so you can take a long view and buy: 1. Stocks selling at a big discount to book value with a catalyst, 2. Stocks selling way out of whack with past relationships with a catalyst, and 3. Dirt-cheap stocks developing technologies of the future with—you guessed it—a catalyst. During this presentation, Michael Murphy will give you the due diligence on each.

Newsletter Contributions

New World Investor Weekly Newsletter

Top picks and investor strategies based on in-depth research that looks at every detail of the businesses, from management quality, technology, and R&D spending to business position and undervalued stock prices.

Learn More
Live Now

Money, Metals, & Mining Virtual Expo

April 20 - 22, 2021